Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
TPCE Banner

Live (Webinar) - Lipscomb University College of Pharmacy


This website is for claiming CE credit after the webinar only. There is a fee for registration. The link to the registration page can be found here:https://secure.touchnet.net/C20974_ustores/web/store_cat.jsp?STOREID=137&CATID=112. Please e-mail Kathryne Channell about any registration questions kathryne.channell@lipscomb.edu.

Date: Mar 13, 2019 11:30 AM - 12:30 PM

Fee

$0.00

CE Hours

1.00

Activity Type

  • Knowledge

Accreditation(s)

Accreditation Council for Pharmacy Education
The Tennessee Pharmacists Consortium for Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

 

   

Objectives

  • Identify new guideline recommendations for sacubitril/valsartan and iron replacement in heart failure with reduced ejection fraction and discuss the supporting literature
  • Outline the most recent guideline-directed treatment recommendations for heart failure with preserved ejection fraction
  • Discuss differences in heart rate and blood pressure goals between heart failure with reduced and preserved ejection fraction
  • Identify recent literature about the use of digoxin and novel oral anticoagulants in the treatment of atrial fibrillation
  • Discuss recent guideline changes and clinical trials which impact the goal blood pressures in patients with hypertension

Speaker(s)/Author(s)

Zac Cox picture

Zac Cox, PharmD, BCPS
Associate Professor, Lipscomb University COP and Health Sciences


Brief Bio : Dr. Cox attended the University of Tennessee at Chattanooga where he studied pre-pharmacy. He received his Doctor of Pharmacy degree from the University of Tennessee College of Pharmacy in 2008. Since graduation, Dr. Cox has completed a pharmacy practice residency at Vanderbilt University Medical Center focusing on Critical Care and Internal Medicine and holds board certification as a pharmacotherapy specialist (BCPS). Currently, Dr. Cox practices at Vanderbilt University Medical Center on the inpatient Heart Failure specialty team and in Vanderbilt's Program for Inter-professional Learning in a heart failure clinic. His research interests focus on outcomes in heart failure management and the use of inotropic agents in Stage D heart failure.

Activity Number

0575-0000-19-008-L01-P
Date: 03/13/19
Time: 11:30 AM - 12:30 PM

CE Hours

1.00